Press Releases from Rosa and Co (34 total)
Dr. Arthur Lo, Theravance, to Discuss a Viral Kinetics Model for Optimizing Comp …
Dr. Lo will present the Webinar “Integration of in vitro data into a viral kinetics model to investigate rapid development of Hepatitis C resistance to…
Dr. Toufigh Gordi to discuss the Selection of Appropriate Mathematical Modeling …
Dr. Gordi, will discuss choice of models and their Impact in the Drug Development Process on November 28, 2012 in Frankfort, Germany
Rosa & Co. LLC,…
Dr. Pratap Singh, to Discuss PK/PD Modeling Analysis of a Compound Targeting Mus …
Dr. Singh, will present “Role of Myostatin in Muscle Growth: Key Learnings From PK/PD Modeling Analysis” Webinar October 17, 2012.
Rosa & Co. LLC today announced…
Dr. Malcolm Rowland, to Discuss Physiologically-Based Pharmacokinetics in Rosa …
Dr. Rowland, will present “Drug development and physiologically based pharmacokinetics” Webinar September 19, 2012
Rosa & Co. LLC today announced that Dr. Malcolm Rowland, Professor Emeritus,…
GlaxoSmithKline and Rosa Present Psoriasis Collaboration Results at 17th Interna …
PhysioPD™ modeling collaboration in psoriasis to be presented September 9-13, 2012.
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and…
Rosa to Present Mechanistic Systems Pharmacology Workshop at 2012 ICSB Conferenc …
Workshop focused on Rosa’s Model Qualification Method to be held August 19th, Toronto, Canada.
Rosa & Co. LLC, a drug development advisory firm with expertise in…
Rosa to Present at 2012 PaSiPhIC Conference
Modeling analysis utilizes AMS/microdosing to improve drug development for infants.
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation,…
Dr. Scott Siler to Discuss DILIsym Model in Rosa’s World-Wide Webinar Series, …
Dr. Siler, will present “The DILIsym™ model and its application to hepatotoxicity testing in drug development” Webinar June 19, 2012
Rosa & Co. LLC today announced…
Rosa to Present Beta Cell Mass Research at 2012 ADA Annual Meeting
Modeling analysis enables development of clinical markers for beta cell mass.
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and…
Dr. Toufigh Gordi to Discuss Pediatric PK Model in Rosa’s World-Wide Webinar S …
Dr. Gordi, will present “Mechanistic PK/PD Modeling in Pediatrics” Webinar May 22, 2012.
Rosa & Co. LLC today announced that Dr. Toufigh Gordi, Rosa & Co,…
Rosa to present two lectures at The European Foundation of Medicinal Chemists Co …
Rosa to Present The MQM Standard and Lead Optimization Using Systems Pharmacology Modeling
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease…
Rosa to Present Systems Pharmacology Workshop at 3rd Annual World PK/PD Summit
Rosa Workshop Presents The MQM Quality Standard For Mechanistic Modeling
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation,…
Rosa to Present at 2012 Keystone Symposia: Advances in Islet Biology
Modeling analysis enables development of biomarkers for beta cell mass.
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation,…
Dr. Joga Gobburu to Discuss the Impact of Pharmacometrics on Drug Approvals in R …
Dr. Gobburu will present “Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions” March 20, 2012.
Rosa & Co. LLC today announced that Dr.…
Rosa PK/PD Collaboration with Pfizer to be Presented at ASCPT 2012
PK/PD analyses used to support the rationale for therapeutic strategies targeting myostatin pathway
Rosa & Co. LLC, a drug development advisory firm with expertise in PK/PD…
Rosa Announces Publication of its PhysioPD™ Model Qualification Method and Ser …
Series of Seminars and Workshops to be held in 2012 across the US and in Europe
Rosa & Co. LLC, a drug development advisory firm with…
Biopontis Alliance Fund and Rosa Announce Strategic Relationship for Early Stage …
Collaboration will combine Rosa’s PhysioPD™ modeling & simulation capabilities with Biopontis’ innovative asset sourcing and financial structure to improve early drug development productivity
Biopontis Alliance, Inc,…
Dr. Hartmut Derendorf to Discuss PK/PD-based Drug Development in Rosa’s World- …
Rosa & Co. LLC today announced that Dr. Hartmut Derendorf, University of Florida, Gainesville, will present a webinar “PK/PD-based Development of Anti-infective Agents” on Monday,…
Rosa to present at 2012 Keystone Symposia: Cancer and Metabolism
Modeling analysis enables understanding efficacy of large numbers of potential drug combinations.
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling…
Dr. Mike Reed to Participate in Roundtable Panel of American Society of Phamacom …
Industry presenters will focus on the Use and Benefits of Physiologic, Mechanistic Models in Drug Development
Rosa & Co. LLC, a drug development advisory firm with…
Pfizer and Rosa to present at 2012 Keystone Symposia: Pathogenesis of Diabetes
Insulin degradation and the mechanisms controlling it have significant impact on glucose homeostasis and diabetes.
Rosa & Co. LLC, a drug development advisory firm with expertise…
Rosa’s Toufigh Gordi to Present at 2nd Annual Pediatric Pharmacology Conferenc …
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced that its Dr. Toufigh Gordi, President of…
Dr. Tristan Maurer to Discuss Translational Modeling in Support of Drug Discover …
Rosa & Co. LLC today announced that Dr. Tristan Maurer, Pfizer Inc., will present a webinar “Translational Modeling & Simulation in Support of Rational Drug…
Dr. Mike Reed Joins Rosa & Co. Executive Management Team
Rosa & Co today announced that Michael Reed, Ph.D., has joined Rosa as Vice President. Dr. Reed brings deep clinical pharmacology and drug development expertise…
Dr. Nick Holford to Discuss the Use of Modeling in Clinical Pharmacology in Rosa …
Rosa & Co. LLC today announced that Dr. Nick Holford will present a webinar “Clinical Pharmacology = Disease Progression + Drug Action” on September 19,…
Rosa’s Christina Friedrich to Lead Model Qualification Workshop at ICSB 2011
The Model Qualification Method is a rigorous, systematic analysis of model relevance, uncertainty, variability, and consistency with data to ensure drug discovery/development models are “fit…
Dr. Rebecca Baillie to Describe PhysioPD™ Model Construction and Testing in Ro …
Rosa & Co. LLC today announced that Dr. Rebecca Baillie will present a webinar “How to build a PhysioPD model” on June 20, 2011 at…
Rosa and FOCUS-IP Announce Strategic Alliance for Enhancing Proof-of-Concept Dru …
Rosa & Co. LLC (rosaandco.com) today announced that it has formed a strategic scientific alliance with FOCUS-IP (focus-ip.de), a leading EU-based drug development advisory firm.…
Rosa Announces Qualification of a Novel Methodology for Prediction of Pediatric …
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced the novel results and qualification of a…
Rosa Diabetes PhysioPD™ Collaboration with Pfizer to be Presented at World PK/ …
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced that results from its Diabetes PhysioPD™ collaboration…
Head of the US FDA Division of Pharmacometrics to Kick-off Rosa’s World-Wide W …
Rosa & Co. LLC today announced that Dr. Jogarao V. Gobburu, Head of the US FDA Division of Pharmacometrics, will present the inaugural webinar in…
Rosa Announces Six Poster Presentations at the American College on Pharmacometri …
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced that it has six posters scheduled during…
Rosa & Co. Announces the Appointment of Sharan A. Pagano as Vice President, Scie …
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced the appointment of Sharan A. Pagano, Vice…
Rosa & Co and Vitalea Science to present at ASPCT 2011 meeting
In collaboration with Vitalea Science, Inc., Rosa & Co will present a poster at the 2011 American Society for Clinical Pharmacology and Therapeutics in Dallas,…
Go To Page:
